Skip to main
STAA

STAAR Surgical (STAA) Stock Forecast & Price Target

STAAR Surgical (STAA) Analyst Ratings

Based on 9 analyst ratings
Hold
Strong Buy 11%
Buy 0%
Hold 89%
Sell 0%
Strong Sell 0%

Bulls say

Staar Surgical Co is positioned favorably within the rapidly expanding global ophthalmic surgical device market, projected to reach $20.1 billion by 2025, reflecting a robust 2.9% compound annual growth rate since 2019. The company has demonstrated significant growth in the phakic intraocular lens (IOL) segment, with market share increasing from 14.3% in 2019 to an estimated 26.5% by 2025, underscoring its competitive edge and innovation in refractive surgery. Additionally, with an enhanced acquisition offer from Alcon, indicating increased recognition of Staar's value and growth potential, the company's operational advancements and strategic positioning further bolster a positive outlook.

Bears say

Staar Surgical has faced significant revenue declines, with a staggering drop of 82% YoY in China during 4Q’24 and continued adverse impacts into 2025, directly contributing to overall financial losses and heightened operational uncertainties. The company's EBITDA losses and cash consumption highlight its struggle to achieve the growth and margin expansion necessary for maintaining premium valuations, leaving the stock trading at a notable discount to historical multiples. Furthermore, the ongoing weakness in China's macroeconomic environment and increased competition may pose prolonged risks to recovery, with potential market revaluation reflecting lower growth expectations and heightened execution risks.

STAAR Surgical (STAA) has been analyzed by 9 analysts, with a consensus rating of Hold. 11% of analysts recommend a Strong Buy, 0% recommend Buy, 89% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of STAAR Surgical and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About STAAR Surgical (STAA) Forecast

Analysts have given STAAR Surgical (STAA) a Hold based on their latest research and market trends.

According to 9 analysts, STAAR Surgical (STAA) has a Hold consensus rating as of Feb 7, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $23.03, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $23.03, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

STAAR Surgical (STAA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.